HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sales & Earnings In Brief: Prestige Brands, Merck, Herbalife, Reckitt

This article was originally published in The Tan Sheet

Executive Summary

Prestige feels effects of J&J relaunches; Merck CEO urges long view on Consumer Care; Herbalife still growing in North America; Reckitt boosts brand equity investments; sales of Bayer’s OTCs “gratifying;” Church & Dwight gummies best expectations; more Sales & Earnings In Brief.

You may also be interested in...



Herbalife Pushes To Counter Pyramid Scheme Narrative

The multilevel marketer of weight-management shakes and other nutritionals says its independent distributor network, far from being a pyramid scheme, in fact is essential in helping people lose weight and adopt healthy lifestyles, according to Herbalife executives.

Reckitt Deals Feed OTC Domination Plan

Reckitt Benckiser CEO Rakesh Kapoor plays up the firm’s potential to dominate the fragmented global consumer health product market and says Reckitt is better positioned than big pharma firms to manage OTC businesses. Reckitt continued its emerging markets focus with OTC deals in Latin America and China.

In Brief

Asthma inhaler bill vote delayed; fatal plant explosion rocks krill oil producer Neptune; ProPhase grows despite weak cold/flu trend; FTC general counsel leaves; Nu Skin acquires NOX Technologies; more news in brief.

Topics

Related Companies

UsernamePublicRestriction

Register

RS124286

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel